FBCTX | RHCTX | FBCTX / RHCTX | |
Total Expense Ratio | 0.39 | 0.44 | 89% |
Annual Report Gross Expense Ratio | 0.39 | 0.44 | 89% |
Fund Existence | 11 years | 10 years | - |
Gain YTD | 8.078 | 8.096 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15B | 15B | 100% |
Annual Yield % from dividends | 2.76 | 2.70 | 102% |
Returns for 1 year | 8.19 | 8.14 | 101% |
Returns for 3 years | 22.73 | 22.59 | 101% |
Returns for 5 years | 20.69 | 20.40 | 101% |
Returns for 10 years | 38.66 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RMDAX | 5.37 | 0.03 | +0.56% |
Virtus Silvant Mid-Cap Growth A | |||
AFDIX | 54.87 | N/A | N/A |
American Century Large Cap Equity Inv | |||
RFNBX | 88.30 | -0.20 | -0.23% |
American Funds Fundamental Invs R2 | |||
SSMGX | 66.76 | -0.18 | -0.27% |
Sit Small Cap Growth | |||
ETIHX | 34.70 | -0.66 | -1.87% |
Eventide Healthcare & Life Sciences I |